Increase in BMD with zoledronic acid in elderly women with osteoporosis and living in LTC
Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trialJAMA Intern Med. 2015 Jun;175(6):913-21
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
181 elderly women with osteoporosis or bone fractures were randomized to receive either one 5-mg dose of zoledronic acid or placebo intravenously. The purpose of this study was to determine whether zoledronic acid was safe and effective for improving bone mineral density in frail elderly women with osteoporosis. Hip and spine bone mineral density were measured at 12 and 24 months post-intervention...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE